Drug search by name

Inotuzumab ozogamicin and QT prolongation

Result of checking the interaction of drug Inotuzumab ozogamicin and disease QT prolongation for safety when used together.

Check result:

Inotuzumab ozogamicin <> QT prolongation

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of inotuzumab ozogamicin may cause increases in QT interval. It is recommended to administer inotuzumab ozogamicin with caution in patients with a history or predisposition for QTc prolongation, those taking medications that are known to prolong QT interval, and in patients with electrolyte disturbances. Obtain electrocardiograms and electrolytes values at baseline, after initiation of treatment, after initiation of drugs known to prolong QTc, and periodically thereafter as clinically indicated.

Inotuzumab ozogamicin

Generic Name: inotuzumab ozogamicin

Brand Name: Besponsa

Synonyms: Inotuzumab Ozogamicin

What is Inotuzumab ozogamicin?